![Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days]({"type":"image" , "src" : "/sda/5925/TOC-Subject-Sample-2021-Bioscience.jpg"})
"Doxycycline in ATTRY69H (p.ATTRY89H) amyloidosis with predominant leptomeningeal manifestation." Amyloid, 20(4), pp. 279–280
Acknowledgements
Magnetic resonance imaging (MRI, ) was performed at the Department of Neuroradiology, LMU University Hospital Munich, in 2012.
Figure 1. Representative MRI of the brain in a patient with leptomeningeal ATTRY69H (p.ATTRY89H) amyloidosis showing abnormally increased leptomeningeal enhancement. Axial, gadolinium-enhancend T1-weighted sequence (TE/TR 17/580 ms; slice thickness 6 mm); 1.5 Tesla MR scanner (Magnetom Avanto, Siemens AG, Germany). A similar distribution pattern was also described in an ATTRY69H patient by Blevins et al. [Citation5].
![Figure 1. Representative MRI of the brain in a patient with leptomeningeal ATTRY69H (p.ATTRY89H) amyloidosis showing abnormally increased leptomeningeal enhancement. Axial, gadolinium-enhancend T1-weighted sequence (TE/TR 17/580 ms; slice thickness 6 mm); 1.5 Tesla MR scanner (Magnetom Avanto, Siemens AG, Germany). A similar distribution pattern was also described in an ATTRY69H patient by Blevins et al. [Citation5].](/cms/asset/d2ca0f5b-561c-4eb1-add9-64a62c8cad7a/iamy_a_829439_f0001_b.jpg)